Table 1.
SAH | ICH | |
---|---|---|
n | 43 | 11 |
Age, years; mean ± SD (range) | 60.7 ± 12.2 (28–86) | 67.6 ± 9.3 (55–85) |
Sex, female; n (%) | 29 (67.4) | 6 (54.5) |
Hunt & Hess, n (%) | ||
Grad I-II | 6 (14.0) | |
Grad III | 12 (27.9) | |
Grad IV-V | 25 (58.1) | |
Time between disease onset and BL sampling, days | 5 (3–8) | 6 (4–9) |
Time between disease onset and FU sampling, days | 27 (19–39) | 26 (19–33) |
Baseline CSF findings | ||
RBC, /μl | 32,000 (10667–96,000) | 30,000 (3093–130,000) |
WBC, /μl | 91 (28–371) | 73 (35–363) |
Total protein, mg/l | 1910 (880–2870) | 2520 (1040–4280) |
FU CSF findings | ||
RBC count, /μl | 106 (13–419) | 72 (3–3072) |
WBC count, /μl | 9 (2–18) | 18 (10–36) |
Total protein, mg/l | 410 (320–690) | 840 (445–1625) |
Data are given as median (interquartile range) unless otherwise specified
BL baseline, CSF cerebrospinal fluid, FU follow-up, ICH intracerebral haemorrhage, RBC red blood cell, SAH subarachnoid haemorrhage, WBC white blood cell